– Chief, Department of Cardiology, Hôpital Bichat, Paris, France.
– Vice President for research of the board of the Assistance Publique-Hôpitaux de Paris network.
– Professor of Cardiology at Université de Paris.
– Chair of the FACT (French Alliance for cardiovascular Clinical Trials) academic research network.
Dr Steg has experience as a clinical trialist in coronary artery disease, diabetes and antithrombotics and has authored > 1 000 peer-reviewed articles. His H-Index is 116 and he has > 76 000 citations. He has been ”highly cited researcher” every year since 2014. He is Senior Associate Editor for Circulation.

Contributions

Omega 3 fatty acids in cardiovascular prevention - Where do we stand? - Discussion and Q&A90th EAS Congress 2022Omega 3 fatty acids in cardiovascular prevention - Where do we stand?Recent trials with Omega 3, lessons to be learned90th EAS Congress 2022Omega 3 fatty acids in cardiovascular prevention - Where do we stand?An update on the results of ODYSSEY outcomes88th EAS Congress 2020PCSK9 Inhibition in high risk patients86th EAS Congress 2018